What we’re working on
The AmEAG works on many different projects, including:
RPS AMR training program
Helping to develop 30 post-Foundation pharmacists in NHS acute trusts and CCGs in London and South East England.
Launched in 2019, this RPS-led initiative was advised by our AmEAG, supported by the HEE Innovation Fund and the UK Clinical Pharmacy Association. It included self-directed learning, face-to-face training, practice-based feedback and a final portfolio review.
Program graduates were awarded a certificate of completion.
Antibiotic Amnesty campaign
What should you do with unwanted medicines? Most patients don’t know, so many medicines end up flushed down the toilet. For antibiotics, this is a problem, because they can end up contributing to Antimicrobial Resistance (AMR).
The Antibiotic Amnesty campaign, initially led by Imperial College, has expanded nationally and increased the number of antibiotics surrendered each year.
Supporting national and international initiatives
We work with other national groups to optimise the use of antimicrobials and contribute to the global strategy for antimicrobial resistance.
We respond to consultations from government departments, regulatory bodies and other healthcare and professional bodies, and also provide support and recognition for important work from other healthcare organisations through our endorsement service.
As a trusted source of expertise, our AmEAG comments on antimicrobial stewardship, resistance, infection prevention and management and other related issues. The latest consultations include:
RPS Antimicrobial Resistance and Stewardship Campaign
With support from the AmEAG, in 2017 we hosted a national campaign to safeguard antibiotics and minimise AMR. Our Antimicrobial Stewardship Policy had six key recommendations on how pharmacy could minimise AMR, and we produced a Quick Reference Guide to AMS for community pharmacy, an AMS Portal and an essential guide to handwashing.
Find out more
Research and innovation in AMR led by pharmacy and our AmEAG
Pharmacy teams play an essential role in AMS, increasingly leading research and innovation which are essential to the global fight against AMR in the UK and across the globe. This list of publications from members of our AmEAG is a small snapshot of the available evidence.